Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

SCOT-HEART (Scottish COmputed Tomography of the HEART) and PROMISE (PROspective Multicenter Imaging Study for Evaluation of chest pain) represent the 2 largest and most comprehensive cardiovascular imaging outcome trials in patients with stable chest pain and provide significant insights into patient diagnosis, management, and outcomes. These trials are particularly timely, given the well-recognized knowledge gaps and widespread use of noninvasive imaging. The overall goal of this review is to distill the data generated from these 2 pivotal trials to better inform the practicing clinician in the selection of noninvasive testing for stable chest pain. Similarities and differences between SCOT-HEART and PROMISE are highlighted, and clinical and practical implications are discussed. Both trials show that coronary computed tomography angiography should have a greater role in the diagnostic pathway of patients with stable chest pain.

Original publication

DOI

10.1016/j.jacc.2015.11.055

Type

Journal article

Journal

J am coll cardiol

Publication Date

23/02/2016

Volume

67

Pages

843 - 852

Keywords

angina pectoris, coronary artery disease, noninvasive cardiac imaging, patient selection, Cardiac Imaging Techniques, Chest Pain, Coronary Angiography, Coronary Artery Disease, Diagnosis, Differential, Electrocardiography, Exercise Test, Humans, Practice Guidelines as Topic, Tomography, Emission-Computed, Single-Photon, Tomography, X-Ray Computed